Word

E NUMBER

Status

Dead

Status Code

606

Status Date

Monday, April 25, 2022

Serial Number

88009537

Mark Type

4000

Filing Date

Thursday, June 21, 2018

Published for Opposition

Tuesday, January 22, 2019

Abandoned Date

Monday, April 25, 2022

Trademark Owner History

Essenlix Corporation - Owner At Publication

Classifications

5 Drug testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids; Medical diagnostic reagents and assays for testing bodily fluids for microorganisms; Medical diagnostic reagents and assays for testing of bodily fluids; Tests for personal wellness, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical testing kits comprising reagents and assays for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

1 Assays for research purposes; Non-medical biological and chemical reagents used for detecting and analyzing molecules in proteins or nucleotides, in vitro and in vivo scientific use, and testing of bodily fluids; Chemical test kits for personal wellness for research use; Chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample for research or laboratory use

44 Medical assistance; Medical consultations; Medical counseling; Medical information; Medical services; Tests for personal wellness, namely testing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

10 Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules, cells, and nucleic acids; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic instruments, namely, instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

42 Detection and identification of nucleic acids, namely DNA and RNA in a sample for scientific, research, and technological purposes

Trademark Events

Apr 25, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Apr 25, 2022

Abandonment - No Use Statement Filed

Sep 22, 2021

Notice Of Approval Of Extension Request E-Mailed

Sep 21, 2021

Sou Extension 5 Granted

Sep 17, 2021

Sou Extension 5 Filed

Sep 21, 2021

Case Assigned To Intent To Use Paralegal

Sep 17, 2021

Teas Extension Received

Mar 17, 2021

Notice Of Approval Of Extension Request E-Mailed

Mar 15, 2021

Sou Extension 4 Granted

Mar 15, 2021

Sou Extension 4 Filed

Mar 15, 2021

Teas Extension Received

Sep 3, 2020

Notice Of Approval Of Extension Request E-Mailed

Sep 1, 2020

Sou Extension 3 Granted

Sep 1, 2020

Sou Extension 3 Filed

Sep 1, 2020

Teas Extension Received

Feb 29, 2020

Notice Of Approval Of Extension Request E-Mailed

Feb 20, 2020

Sou Extension 2 Granted

Feb 20, 2020

Sou Extension 2 Filed

Feb 20, 2020

Teas Extension Received

Feb 20, 2020

Teas Change Of Correspondence Received

Feb 20, 2020

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 20, 2020

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Sep 11, 2019

Notice Of Approval Of Extension Request E-Mailed

Sep 9, 2019

Sou Extension 1 Granted

Sep 9, 2019

Sou Extension 1 Filed

Sep 9, 2019

Teas Extension Received

Mar 19, 2019

Noa E-Mailed - Sou Required From Applicant

Jan 22, 2019

Official Gazette Publication Confirmation E-Mailed

Jan 22, 2019

Published For Opposition

Jan 2, 2019

Notification Of Notice Of Publication E-Mailed

Dec 11, 2018

Approved For Pub - Principal Register

Dec 10, 2018

Examiner's Amendment Entered

Dec 10, 2018

Notification Of Examiners Amendment E-Mailed

Dec 10, 2018

Examiners Amendment E-Mailed

Dec 10, 2018

Examiners Amendment -Written

Nov 17, 2018

Teas/Email Correspondence Entered

Nov 17, 2018

Correspondence Received In Law Office

Nov 9, 2018

Assigned To Lie

Oct 31, 2018

Teas Response To Office Action Received

Aug 22, 2018

Notification Of Non-Final Action E-Mailed

Aug 22, 2018

Non-Final Action E-Mailed

Aug 22, 2018

Non-Final Action Written

Aug 16, 2018

Assigned To Examiner

Jun 27, 2018

New Application Office Supplied Data Entered In Tram

Jun 25, 2018

New Application Entered In Tram